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ABSTRACT. In this study we aimed to: 1) examine whether there were differences
in mental health and quality of life of liver transplant recipients according to etiology
that led to transplantation (alcoholic cirrhosis, Hepatitis B/C Virus, hepatocellular
carcinoma and others); and 2) to compare mental health and quality of life between liver
transplant and cirrhotic patients, according to etiologies that most often lead to liver
transplantation (alcoholic and Hepatitis C Virus). Two patient groups participated: 168
transplant recipients and 63 cirrhotic patients. Mental health was assessed by the
Hospital Anxiety and Depression Scale and quality of life by the SF-36 Health Survey.
We found the following results: 1) statistically significant differences were found in
anxiety, depression, general health, and vitality; in all of them, transplant patients due
to Hepatitis C Virus showed the highest impairment and transplant patients due to
alcoholic cirrhosis showed the lowest deterioration; 2) cirrhotic patients, compared to
transplanted, and patients with Hepatitis C Virus, compared to alcoholic liver patients,
were the groups with greater biopsychosocial impairment. In the absence of interactive
effects between factors groups and etiology, Hepatitis C Virus patients had higher
biopsychosocial impairment than alcoholic liver patients, regardless of whether or not
they underwent transplant.
1 This investigation was financed by the Ministry of Science and Innovation of Spain (Register
PSI2009-07713).
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RESUMEN. En este estudio se plantea: 1) analizar diferencias en salud mental y calidad
de vida entre trasplantados hepáticos en función de la etiología desencadenante del
trasplante (etílica, Virus de la Hepatitis B/C, hepatocarcinoma y otras), y 2) comparar
la salud mental y la calidad de vida entre trasplantados hepáticos y enfermos cirróticos
en función de las etiologías que con más frecuencia desencadenan el trasplante hepático
(etílica y Virus de la Hepatitis C). Se seleccionaron dos grupos: 168 trasplantados y
63 cirróticos. Se empleó la Escala Hospitalaria de Ansiedad y Depresión y el Cues-
tionario de Salud SF-36. Los resultaron indicaron: 1) diferencias significativas en las
variables ansiedad, depresión, salud general y vitalidad; en todas ellas el mayor deterioro
correspondió a trasplantados con el Virus de la Hepatitis C y el menor a etílicos, 2)
enfermos cirróticos versus trasplantados hepáticos, y enfermos con el Virus de la
Hepatitis C versus etílicos, fueron los grupos con mayor deterioro biopsicosocial. Ante
la inexistencia de efectos interactivos entre los factores grupo y etiología, se concluye
que los pacientes con Virus de la Hepatitis C presentan mayor deterioro biopsicosocial
en comparación con pacientes etílicos, independientemente de que hubieran sido o no
trasplantados.
PALABRAS CLAVE. Bienestar biopsicosocial. Trasplante hepático. Cirrosis hepática.
Etiologías desencadenantes del trasplante. Estudio ex post facto.
Liver transplantation is a completely consolidated therapy that improves patients’
quality of life, although they do not achieve the same levels as the general population
(Karam et al., 2003; Sumskiene, Sumskas, Petrauskas, and Kupcinskas, 2006; Taylor,
Franck, Gibson, and Dhawan, 2005). Thus, for example, in a study that analyzed health-
related quality of life in three groups (cirrhotic patients who presented diverse levels
of severity -mild, moderate, and severe-, liver transplant patients, and healthy population),
it was found that the quality of life of the transplant recipients did not reach the levels
of the healthy population, although it was significantly better than that of the cirrhotic
patients, especially compared to those who were in advanced stages of the liver disease
(Pantiga et al., 2005). Similarly, another study that compared the same groups also found
that the best functioning corresponded to the healthy people and the worst to the
transplant candidates. In comparison to the last group, the liver transplant recipients
had fewer limitations in their psychosocial functioning, but in comparison to the control
group, some aspects of their functioning were worse, especially the physical and social
dimensions (O’Carroll, Turner, Flatley, McGregor, and Hayes, 2008).
The quality of life of liver transplant recipients may be conditioned by the diverse
etiologies that lead to transplantation, with alcoholic cirrhosis and cirrhosis associated
with Hepatitis C Virus (HCV) being the main indications. In the same vein, most of the
investigations report that the quality of life of HCV transplant recipients is worse than
that of other transplant recipients: poorer physical functioning (Feurer et al., 2002;
Paterson et al., 2000), higher presence of anxious-depressive symptomatology (De Bona
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et al., 2000; Dwight et al., 2000; Paterson et al., 2000), fibromyalgia (Goulding, O’Connell,
and Murray, 2001) and fatigue (Kallman et al., 2007). In general, the studies conclude
that alcoholic cirrhotic patients have better quality of life than cirrhotic patients with
HCV, both before and after the transplant (Burra et al., 2005). Nevertheless, other studies
reach different, and even contradictory, conclusions: transplant recipients with alcoholic
cirrhosis or cryptogenic cirrhosis have worse quality of life than patients with autoimmune
hepatitis or viral hepatitis (Aadahl, Hansen, Kirkegaard, and Groenvold, 2002); HCV
transplant recipients have worse quality of life than patients with hepatocellular carci-
noma or primary biliary cirrhosis (Estraviz et al., 2007); and alcoholic cirrhotic patients
display worse psychological functioning in comparison to HCV-infected patients (Minazzato
et al., 2009).
Likewise, regarding the studies focused on analyzing the influence of the etiology
of cirrhosis on the biopsychosocial well-being of patients who are candidates for a liver
transplant, the conclusions are also contradictory: cirrhotic patients with Hepatitis B
Virus (HBV) have better quality of life than cirrhotic HCV patients or than patients with
primary biliary cirrhosis (Bondini et al., 2007); patients with autoimmune hepatitis dis-
play higher levels of clinical anxiety in comparison to patients who suffer alcoholic
cirrhosis or hepatocellular carcinoma (Santos et al., 2010), and the etiology of the
cirrhosis does not determine the quality of life (Jurado et al., 2011).
In view of the relevance of this topic in clinical practice, the scarcity of this topic
in Spain, and of the controversial results of previous investigations, we aimed to
continue to analyze the differences between pre- and post- transplant liver patients as
a function of etiology of liver disease in the Spanish population. Therefore, in the
present ex post facto study (Montero and León, 2007), we proposed two main goals:
1) firstly, to determine whether there are any differences in mental health and quality
of life of liver transplant recipients as a function of the etiology of the disease that led
to the transplant (alcoholic, HBV, HCV, hepatocellular carcinoma, and others), and 2)
secondly, to compare the mental health and quality of life between liver transplant
recipients and cirrhotic patients who are potential transplant candidates as a function
of the etiologies that most frequently lead to liver transplant (alcoholic and HCV).
Likewise, we aimed to control demographic and clinical parameters as covariables, in
order to highlight in the analysis the influence of factors groups (liver transplant
recipients and cirrhotic patients) and etiology (alcoholic and HCV).
Method
Participants
To carry out this study, two groups of patients were selected: 168 liver transplant
recipients and 63 patients with hepatic cirrhosis. The group of transplant recipients was
made up of 126 men and 42 women, mean age 50.42 years (SD = 10.57 years). They all
had received a first liver transplant five years ago, on average, proceeding from a donor
who had died from the following causes: cerebrovascular accidents (60.5%),
craneoencephalic traumas (34.1%), and others (5.4%). This group was divided into five
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subgroups as a function of the etiology of the disease that led to the transplant:
alcoholic (n = 59), HCV (n = 40) hepatocellular carcinoma (n = 28), HBV (n = 14), and
others (n = 27). The group of cirrhotic patients was made up of 58 men and 5 women,
mean age 56.16 years (SD = 7.72 years). This group was divided into two subgroups
depending on the etiology of the disease: alcoholic cirrhosis (n = 38) and HCV (n = 25).
Instruments
– Clinical variables. In the case of the transplant recipients, we collected the
following clinical data related to the diverse stages of the transplant: a)
preoperative: etiology of the disease that led to transplant (alcoholism, HBV,
HCV, hepatocellular carcinoma, and others), scores on the Child-Pugh scale
(mild, moderate, and severe) and on the Model for End-stage Liver Disease
(MELD) scale; b) perioperative: quality of the graft implanted (optimal or
suboptimal); and c) postoperative: complications of the function of the graft
(rejection), complications of the depressed immune system (Epstein Barr Virus -
EBV- and cytomegalovirus -CMV), hospital admissions due to medical problems
after transplant, and type of immunosuppressive medication prescribed
(cyclosporine, tacrolimus, micophelonate, cyclosporine + micophelonate, and
tacrolimus + micophelonate). In the case of the cirrhotic patients, we collected
the same data as for the transplant recipients in the preoperative stage: etiology
of the liver pathology and scores on the Child-Pugh and MELD scales.
– Hospital Anxiety and Depression Scale (HADS; Zigmond and Snaith, 1983). This
instrument has 14 items, 7 of depression and 7 of anxiety, in which patients
indicate how they felt during the past week, selecting one of four response
options. The test provides two scores, one for anxiety and the other for depression.
According to Herrero et al. (2003), the optimal cut-off point for the screening
of depressive disorders is 5 and is 8 for the screening of anxiety disorders in
several clinical populations in Spain. In Spanish studies, Cronbach’s alpha values
range between .80 and .90. We used the version developed by Caro and Ibáñez
(1992). This questionnaire has been described as one of the most commonly
used in liver transplantation, as well as, has shown suitable psychometric properties
in this clinical population (Jay, Butt, Ladner, Skaro, and Abecassis, 2009).
– SF-36 Health Survey (Alonso, Prieto, and Antó, 1995). This is made up of 36
items, each one with various response alternatives that provide a health status
profile. The test explores eight dimensions: physical functioning, role limitations
due to physical problems (physical-role), bodily pain, general health perceptions,
vitality, social functioning, role limitations due to emotional problems (emotional-
role), and general mental health. In each dimension, a score ranging from 0
(worse health status) to 100 (better health status) is obtained. Alonso et al.
studied the psychometric properties of this test in Spanish population and found
that internal consistency (Cronbach’s alpha) of the diverse dimensions ranged
between .45 and .94, with a mean value of .78, and always above the value of
.70, except for the dimension social functioning, which did not exceed .45. For
test-retest reliability, the correlation coefficients ranged between .51 and .85.
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Procedure
Before beginning the psychological assessment of the participants of the study,
they were informed about the study, their doubts were clarified, and written informed
consent was obtained, emphasizing that their participation was voluntary and they
could leave the study at any time, without having to offer any explanation and without
this having any negative effects on their medical care.
In the two groups (liver transplant recipients and cirrhotic patients), we took the
following inclusion criteria into account: being over 18 years of age, having a reading/
writing level that allowed them to complete the diverse scales employed, not presenting
any incapacitating state (severe encephalopathy, coma, etc.) to understand items of
questionnaires at the moment of assessment, and giving their written informed consent
to participate in the investigation. Other specific inclusion criteria were: in the transplanted
group, having received a first liver transplant (retransplant recipients were excluded)
proceeding from a deceased donor; and in the group of cirrhotic patients, being admitted
in the Digestive Diseases Unit with alcoholic cirrhosis or cirrhosis associated with HCV,
for a medical study to determine their inclusion on the waiting list for subsequent liver
transplant (possible recipients of a combined liver-kidney transplant were excluded)
proceeding from a deceased donor.
Both groups of patients were selected from the University Hospital Virgen del
Rocío of Seville, taking into account that the Ethics and Health Research Commission
had previously approved the adequacy and implementation of this investigation. Once
we had received approval, the medical data of the patients were obtained through the
Hepatic-Biliary-Pancreatic Surgery and Liver Transplant Unit and from the Digestive
Diseases Unit.
To select the group of transplant recipients, we started with a clinical population
made up of all the patients in Seville who had received a liver transplant from a deceased
person during the 1990-2007 interval. During this time interval, 662 liver transplants were
carried out in adults, of whom 236 died. Of the 426 living transplant recipients, 28 could
not be located and 230 did not meet the following inclusion criteria: not being able to
read or write, not wishing to participate, and having been retransplanted. We finally
assessed 168 patients.
To select the group of cirrhotic patients, we started with all the patients who,
during a 2-year interval (2009 and 2010), had been scheduled for admission in the
Digestive Diseases Unit in order to undergo a pre-liver transplant study due to the
advanced state of their hepatic pathology. During this time interval, 83 patients were
admitted; we excluded 20 of them because they did not meet the following inclusion
criteria: not being able to read or write, not wishing to participate, suffering very
uncommon etiologies -HBV, autoimmune and cryptogenic- and being under study for a
liver-kidney transplant. We finally assessed 63 patients.
Data analyses
All the analyses were performed with the SPSS 19.0 statistical package. To compare
the categorical variables in the diverse groups, we used Pearson’s chi-square statistic,
and to compare the continuous variables among the five subgroups of transplant
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recipients with different etiologies, we used the Kruskal-Wallis statistic (with post hoc
analysis by means of the Mann-Whitney U statistic). We also applied Analysis
of Covariance (ANCOVA), to analyze the influence of two independent variables
with two levels in each variable: groups (liver transplant recipients and cirrhotic patients)
and etiology (alcoholic and HCV). This analysis allowed us to control the possible
influence of clinical (MELD and Child-Pugh scores) and demographic variables (age and
gender).
Results
Firstly, we compared the clinical data of the liver transplant recipients taking into
account the five types of etiologies that determined the transplant (see Table 1). We
found no statistically significant differences in variables such as MELD scores (p = .07),
quality of the graft (p = .26), rejection of the graft (p = .52), presence of EBV (p = .44),
and hospital admissions due to medical complications after the transplant (p = .07).
Other clinical variables (Child-Pugh, CMV, and type of immunosuppressive medication)
could not be compared because there was a very small number of patients in some
levels.
TABLE 1. Comparisons in clinical data among liver transplant patients.
 
Etiology leading to 
transplant 
MELD  
Mean (SD) 
Graft quality (%) Graft rejection 
(%) 
Presence of 
EBV (%) 
Hospital 
Admissions (%) 
Alcohol 
(n = 59) 
17.24 (3.96) Optimal: 69.5 
Suboptimal: 30.5 
Yes: 22 
No: 78 
Yes: 67.8 
No: 32.2 
Yes: 10.2 
No: 89.8 
HCV 
(n = 40) 
17.69 (3.84) Optimal: 80 
Suboptimal: 20 
Yes: 25 
No: 75 
Yes: 65 
No: 35 
Yes: 25 
No: 75 
Hepatocarcinoma 
(n = 28) 
16 (3.51) Optimal: 57.1 
Suboptimal: 42.9 
Yes: 21.4 
No: 78.6 
Yes: 78.6 
No: 21.4 
Yes: 14.3 
No: 85.7 
HBV 
(n = 14) 
18.69 (2.68) Optimal: 78.6 
Suboptimal: 21.4 
Yes: 35.7 
No: 64.3 
Yes: 50 
No: 50 
Yes: 35.7 
No: 64.3 
Others 
(n = 27) 
17.52 (4.82) Optimal: 77.8 
Suboptimal: 22.2 
Yes: 37 
No: 63 
Yes: 70.4 
No: 29.6 
Yes: 29.6 
No: 70.4 
Intergroup 
comparisons 
H (4,168) = 
8.61 
(p = .07) 
Ȥ2 = 0.56 
(p = .26) 
Ȥ2 = 3.18 
(p = .52) 
Ȥ2 = 3.74 
(p = .44) 
Ȥ2 = 8.58 
(p = .07) 
Upon comparing mental health and quality of life among the five subgroups of liver
transplant recipients of various etiologies, we found statistically significant differences
in the variables anxiety (p = .05), depression (p = .04), general health (p = .004), and
vitality (p = .03; see Table 2). In all of these variables, we found the same results, that
is, the subgroup of HCV transplant recipients showed greater impairment, and the
subgroup of alcoholic transplant recipients enjoyed greater well-being.
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TABLE 2. Comparisons in mental health (HADS) and quality of life (SF-36) among
liver transplant patients with various etiologies.
Etiology leading to transplant Psychological 
variables 
 
Alcohol 
(n = 59) 
M (SD) 
HCV 
(n = 40) 
M (SD) 
Cancer1  
(n = 28) 
M (SD) 
HBV 
(n = 14) 
M (SD) 
Others 
(n = 27) 
M (SD) 
 
Contrast 
statistic 
 
p 
HADS
2
        
Anxiety 3.76 (3.05) 6.48 (4.77) 5.54 (4.18) 5.71 (4.26) 6.11 (4.96) 9.505 .05* 
Depression 3.42 (3.05) 5.40 (4.14) 3.93 (4.24) 4.43 (3.10) 3.56 (4.19) 9.659 .04* 
 
SF-36
3
        
Bodily pain 74.84 (26.66) 62.07 (31.69) 62.39 (33.10) 65.35 (29.49) 72.29 (27.72) 6.898 .14 
Physical-role 77.54 (24.43) 68.59 (32.87) 58.03 (36.35) 66.96 (28.84) 75.46 (26.34) 7.176 .12 
Mental health 77.11 (19.01) 62.87 (26.30) 76.07 (20.69) 70.71 (17.19) 72.22 (21.36) 8.811 .06 
General health 73.77 (17.81) 56.00 (24.94) 62.85 (24.33) 57.21 (19.64) 65.07 (26.22) 15.619 .004** 
Vitality 72.19 (21.49) 57.81 (24.86) 64.73 (23.94) 59.82 (24.35) 65.41 (22.96) 10.459 .03* 
Social 
functioning 
77.96 (23.36) 68.75 (31.52) 69.19 (28.76) 69.63 (31.65) 75.00 (29.41) 2.777 .59 
Emotional-role 80.08 (22.37) 63.95 (34.56) 69.34 (30.76) 79.16 (25.89) 78.08 (24.80) 5.954 .20 
Physical 
functioning 
72.71 (25.19) 64.12 (28.30) 66.42 (26.27) 76.78 (22.32) 79.25 (24.12) 8.274 .08 
Note: 1Hepatocarcinoma; 2the higher score, the worse mental health; 3the lower score, the worse
quality of life; * p < .05, ** p < .01
From the post hoc analyses with these four variables, statistically significant
differences were found among the following subgroups: alcoholic transplant recipients
and HCV transplant recipients, in the variables anxiety (p = .006), depression (p = .009),
general health (p < .001), and vitality (p = .002). Significant differences were found
between the HCV transplant recipients and those who suffered from other etiologies in
the variable depression (p = .013); and between the alcoholic transplant recipients and
the HBV transplant recipients, in the dimension general health (p = .007). In the latter
two comparisons, the transplant recipients with chronic viral hepatitis (B and C) suffered
greater impairment too (see Table 3).
TABLE 3. Intergroup comparisons between liver transplant
patients with various etiologies.
 
Variables 
 
Alcohol 
and 
HCV 
Alcohol 
and 
cancer1 
Alcohol 
and 
HBV 
Alcohol 
and 
others 
HCV 
and 
cancer1 
HCV 
and 
HBV 
HCV 
and 
others 
cancer1 
and 
HBV 
cancer1 
and 
others 
HBV 
and 
others 
 Contrast statistic (p) 
HADS:           
Anxiety -2.73 
(.006**) 
-1.89 
(.05) 
-1.54 
(.12) 
-1.90 
(.05) 
-0.62 
(.53) 
-0.56 
(.57) 
-0.35 
(.72) 
-0.18 
(.85) 
-0.29 
(.76) 
-0.16 
(.86) 
Depression -2.59 
(.009**) 
-0.03 
(.97) 
-1.22 
(.22) 
-0.70 
(.48) 
-1.94 
(.05) 
-0.37 
(.70) 
-2.47 
(.01*) 
-0.98 
(.32) 
-0.48 
(.62) 
-1.29 
(.19) 
SF-36:           
General 
health 
-3.61 
(< 
.001**) 
-1.78 
(.07) 
-2.70 
(.007**) 
-1.48 
(.13) 
-0.98 
(.32) 
-0.35 
(.72) 
-1.58 
(.11) 
-0.96 
(.33) 
-0.43 
(.66) 
-1.06 
(.28) 
Vitality -3.04 
(.002**) 
-1.36 
(.17) 
-1.87 
(.06) 
-1.53 
(.12) 
-0.98 
(.32) 
-0.37 
(.73) 
-1.29 
(.19) 
-0.55 
(.58) 
-0.26 
(.79) 
-0.77 
(.43) 
Note: 1Hepatocarcinoma; * p < .05, ** p < .01.
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In the Analysis of Covariance (ANCOVA), we used two factors (groups and etiology)
with two levels in each factor: liver transplant versus cirrhotic patients (groups), and
alcohol versus HCV (etiology). The scores in the MELD and Child-Pugh scales, age,
and gender were defined as covariates (see Table 4).
TABLE 4. Comparisons in clinical and demographic data among
the groups under study.
* p < .05, ** p < .01.
Regarding the interactive effects analyzed with the ANCOVA between the factors
groups and etiology, no statistically significant relationships were found in any of the
variables studied (see Table 5). These results indicate that the effects that exert each
one of these factors (groups and etiology) on the variables related to mental health and
quality of life are independent of each other. It could be said that the HCV patients
presented greater biopsychosocial impairment than the alcoholic liver patients,
independently of whether or not they had been transplanted (see Figures 1 and 2).
Groups 
MELD 
Mean (SD) 
Child-Pugh 
 (%) 
Age 
Mean (SD) 
Gender 
 (%) 
Liver transplant 
patients 
    (n = 99) 
17.44 (3.89) Mild: 4.2 
Moderate: 44.2 
Severe: 51.6 
53.24 (7.58) Men: 76.8 
Women: 23.2 
Cirrhotic patients 
(n = 63) 
15.53 (5.02) Mild: 19 
Moderate: 46 
Severe: 35 
56.16 (7.72) Men: 92.1 
Women: 7.9 
Intergroup 
comparisons 
F (1,160) = 7.28 
(p = .008**) 
Ȥ2 = 16.60  
(p = .005**) 
F(1,160) = 5.39 
(p = .02*) 
Ȥ2 = 5.27 
(p = .02*) 
Etiology 
MELD 
Mean (SD) 
Child-Pugh 
 (%) 
Age 
Mean (SD) 
Gender 
 (%) 
Alcohol 
(n = 97) 
16.77 (4.72) Mild: 8.4 
Moderate: 44.2 
Severe: 47.4 
55.06 (6.93) Men: 91.8 
Women: 8.2 
HCV 
(n = 65) 
16.46 (4.19) Mild: 12.7 
Moderate: 46 
Severe: 41.3 
53.35 (8.77) Men: 69.1 
Women: 30.9 
Intergroup 
comparisons 
F(1,160) = 0.44 
(p = .50) 
Ȥ2 = 1.02 
(p = .59) 
F(1,160) = 1.76 
(p = .18) 
Ȥ2 = 12.27 
(p < .001**) 
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TABLE 5. Comparisons in mental health (HADS) and quality of life (SF-36)
between liver transplant and cirrhotic patients as a function of etiology.
Note: 1The higher score, the worse mental health; 2the lower score, the worse quality of life; * p
< .05, ** p < .01.
 
 Groups Etiology Main Effects Interactive 
effects 
Variables 
 
Liver 
transplant 
(n = 99) 
M (SD) 
Cirrhotic 
patients 
(n = 63) 
M (SD) 
Alcohol 
(n = 97) 
M (SD) 
HCV 
(n = 65) 
M (SD) 
Groups 
F(1,160) 
(p) 
Etiology 
F(1,160) 
(p) 
F(1,160) 
(p) 
HADS1:        
Anxiety 4.86 (4.04) 8.40 (4.90) 5.49 (4.40) 7.34 (4.96) 21.23 
(< .001**) 
4.73 
(.03*) 
1.39 (.24) 
Depression 4.22 (3.64) 6.87 (4.61) 4.64 (3.83) 6.17 (4.66) 10.82 
(.001**) 
6.24 
(.01*) 
0.87 (.35) 
SF-362:        
Bodily 
   pain 
69.68 
(29.33) 
59.87 
(32.88) 
70.80 
(29.43) 
58.50 
(32.12) 
4.62  
(.03*) 
3.29 
(.07) 
0.04 (.82) 
Physical- 
   role 
73.92 
(28.33) 
45.83 
(35.33) 
67.26 
(33.08) 
56.63 
(34.69) 
28.03  
(< .001**) 
3.43 
(.06) 
0.36 (.54) 
Mental  
   health 
71.36 
(23.20) 
58.96 
(23.57) 
71.54 
(20.55) 
59.07 
(26.96) 
10.49 
(.002**) 
7.59 
(.007**) 
0.34 (.55) 
General 
   health 
66.59 
(22.63) 
37.06 
(18.16) 
61.46 
(23.38) 
45.63 
(25.61) 
74.36 
(< .001**) 
20.54 
(< .001**) 
0.35 (.55) 
Vitality 66.32 
(23.89) 
43.94 
(24.64) 
63.15 
(24.87) 
49.32 
(26.81) 
35.07 
(< .001**) 
10.40 
(.002**) 
0.003 (.96) 
Social 
   functioning 
74.24 
(27.18) 
57.33 
(30.49) 
72.67 
(25.59) 
60.19 
(33.57) 
13.67 
(< .001**) 
9.64 
(.002**) 
0.09 (.76) 
Emotional- 
   role 
73.56 
(28.89) 
62.83 
(32.98) 
75.60 
(26.92) 
60.12 
(34.18) 
3.33 
(.07) 
7.79 
(.006**) 
0.002 (.96) 
Physical 
   functioning 
69.24 
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FIGURE 2. Mean scores on quality of life (SF-36) in liver transplant and cirrhotic
groups as a function of HCV and alcoholic etiologies.
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With regard to the main effects (see Table 5), we found statistically significant
differences among the groups of transplant recipients and cirrhotic patients in the
variables anxiety (p < .001), depression (p = .001), bodily pain (p = .03), physical-role
(p < .001), mental health (p = .002), general health (p < .001), vitality (p < .001), social
functioning (p < .001), and physical functioning (p < .001). In all these variables, the
cirrhotic patients, in comparison to the liver transplant recipients, displayed greater
biopsychosocial impairment. We also found statistically significant differences among
the groups as a function of the etiology of the disease in the variables anxiety (p = .03),
depression (p = .01), mental health (p = .007), general health (p < .001), vitality (p = .002),
social functioning (p = .002), emotional-role (p = .006), and physical functioning (p = .02).
In all of them, the viral patients had poorer well-being in comparison to the alcoholic
liver patients.
Discussion
This research continues to study quality of life among various populations, which
still remains a focus of scientific interest in Health Psychology, as can be observed from
the development of new questionnaires about this construct (Verdugo, Arias, Gómez,
and Schalock, 2010). As well as, this is also observed in the study of the psychometric
properties of known tools of quality of life in other clinical populations (Van Esch, Den
Oudsten, and De Vries, 2011).
With regard to the first goal we had posed, after verifying that the five subgroups
of transplant recipients were homogeneous in the main medical variables, we found that
the most important differences were concentrated among the groups of alcoholic liver
patients and the HCV patients; the latter presented poorer well-being, specifically, more
anxious-depressive symptomatology, worse perception of their general health, and less
vitality. Likewise, among the HCV patients, the levels of depressive symptomatology are
above clinical threshold, according to Herrero et al. (2003). As well as, they show worse
scores than Spanish nonclinical population in general health and vitality dimensions
(Alonso et al., 1998). These results are in the same vein as other studies that confirm
a higher incidence of anxious-depressive symptomatology, phobias, and paranoid ideation
in these transplant recipients; all of this is conditioned by the fear of HCV recurrence
(Burra et al., 2005; De Bona et al., 2000; Dwight et al., 2000; Paterson et al., 2000),
despite no physical complications of liver disease are present (Bownik and Saab, 2010).
In this sense, although the majority of the transplant recipients perceive an uncertain
future regarding the survival of the graft, in the case of the HCV transplant patients,
the degree of uncertainty is higher because they are aware of the nonexistence of any
effective prophylaxis against a relapse of this virus. This could generate a state of
helplessness with negative consequences on the psychological and physical well-being
of these patients, especially if it is taken into account that, if there is a relapse of HCV
after the transplant, it would advance to a new cirrhosis in 20-30% of the cases after
five years. In contrast, the HBV transplant recipients were only different from the
alcoholic liver patients in their perception of their general health, with the viral patients
displaying greater impairment. In this area, it should be taken into account that there
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is also some risk of relapse in HBV but, in contrast to HCV, there is a preventive
treatment during and after the transplant. This might explain why other mood-related
areas -which were assessed with the HADS, because it detects the presence of negative
expectations about the future (hopelessness, pessimism, catastrophic thoughts)- were
less affected in these patients.
With regard to the second goal, after controlling the clinical and demographic
variables by means of ANCOVA, important differences in mental health were found.
Specifically, the patients with cirrhosis presented more anxiety-depressive symptomatology
(HADS), which exceeds clinical threshold in both subscales (Herrero et al., 2003), and
worse general mental health (SF-36) than the liver transplant recipients. Moreover, in
both groups, the HCV patients, in comparison to the alcoholic liver patients, showed
more emotional distress and clinical significance was reached in depression subscale
(Herrero et al., 2003). To explain these results, we emphasize the situation that the
cirrhotic patients were undergoing; they were all hospitalized for a medical assessment
that would determine their inclusion on the waiting list. Consequently, for the patients,
it was an interval charged with uncertainty, which has negative repercussions on their
emotional state. To this must be added the negative anticipations these patients usually
have and which disappear after the transplant; which are caused by the following
factors: ignorance about the benefits of the surgery versus the associated risks, the
impossibility of estimating the time they would have to wait to be transplanted due to
the scarcity of organs, and loss of freedom because they must be located 24 hours a
day if they are included on the waiting list (Díaz-Domínguez, Pérez-Bernal, Pérez-San-
Gregorio, and Martín-Rodríguez, 2006; Martin, Stone, Scott, and Brashers, 2010). These
negative anticipations could be the basis of the affective impairment found between
cirrhotic and HCV patients, because fear is a nonspecific emotion related to both
depressive and anxiety disorders (Watson, Clark, and Stasik, 2011). In both groups
(transplant recipients and cirrhotic patients) and in the same vein as other investigations
(De Bona et al., 2000; Dwight et al., 2000; Paterson et al., 2000), the HCV patients, in
comparison to the alcoholic liver patients, presented greater emotional impairment (more
anxiety-depressive symptomatology -HADS- and worse general mental health -SF-36).
This can be explained by the habitually worse clinical conditions of these patients,
because, on the one hand, in the pre-transplant phase, if the organ does not arrive on
time, this could mean their exclusion from the waiting list, thereby increasing their
negative expectations about their imminent death, and on the other hand, in the post-
transplant phase, they could suffer a relapse of the virus (Burra et al., 2005). All the
above could also explain why the dimension referring to the emotional-role is more
affected in the viral patients than in the alcoholic liver group.
Likewise, when focusing on the quality of life from a perspective more closely
related to the physical aspects, we also found greater impairment in the cirrhotic
patients than in the liver transplant recipients in the following dimensions: bodily pain,
physical-role, vitality, and physical functioning. Moreover, these scores among cirrhotic
patients are very different from Spanish general population’s mean levels, above all in
vitality, physical-role and physical functioning dimensions (Alonso et al., 1998). This
finding is explained because the cirrhotic patients were in an advanced stage of their
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hepatopathy, which implied a threat to their quality of life because of the symptoms of
decompensated cirrhosis: esophageal varices, ascites, encephalopathy, etc. Along the
same lines as other investigations (Feurer et al., 2002; Paterson et al., 2000), the greatest
impairment in the dimensions of vitality and physical functioning corresponded to the
HCV patients, both in cirrhotic patients and transplant recipients, and these scores are
also very different to Spanish general population’s mean levels (Alonso et al. 1998). In
this sense, it should be taken into account that patients with alcoholic cirrhosis can
exert some control over their disease through absolute abstention from alcohol and the
practice of healthy habits, whereas patients with HCV cannot exert any control because
this virus persists in the organism, which could explain a greater physical impairment
of these patients both before and after the transplant.
From a social perspective, the viral patients, in comparison to the alcoholic liver
patients, presented a higher degree of impairment in the social functioning dimension
regardless of whether or not they had been transplanted. Moreover, this deterioration
in social domain was very relevant in comparison to Spanish general population’s social
functioning (Alonso et al., 1998). A possible explanation is that HCV patients, independently
of the stage of the disease they are undergoing, fear the possibility of transmitting the
virus to their friends and relatives, which could hinder their social and family activities.
With regard to this, the feeling of guilt and shame provoked by the disease has been
described by HCV transplant recipients as one of the determinant factors of their quality
of life after the transplant (Dudley, Chaplin, Clifford, and Mutimer, 2007; Strauss and
Teixeira, 2006).
Lastly, as reflected in the dimension of general health, the HCV patients, in comparison
to the alcoholic liver patients, perceive themselves as less healthy, independently of
whether or not they were transplanted. Likewise, their self-perception of health is much
worse than that of Spanish nonclinical population (Alonso et al., 1998). This could be
due to the fact that the viral patients have to undergo more medical controls because,
before the transplant, they have a high risk of developing hepatocellular carcinoma, and
after the transplant, they could be reinfected with the same virus. In fact, long-term graft
survival is notably lower in liver transplant recipients due to HCV than in people whose
transplant was due to other etiologies (Forman, Lewis, Berlin, Feldman, and Lucey,
2002).
On the other hand, among the limitations of this study, the following ones are
highlighted. First, this research has a cross-sectional design, therefore, no conclusions
could be reached about the results in terms of evolution (changes from pre- to post-
transplant phase). On the other hand, some subgroups had very few participants (i.e.,
HBV patients), therefore, this fact limits external validity of results with regard to this
clinical condition.
In conclusion, psychological intervention is essential during the entire process of
liver transplant, but particularly for HCV patients. In addition, specific psychological
interventions would improve the psychosocial well-being of these patients, and likewise,
this would improve their therapeutic adherence, in view of worse quality of life before
treatment for HCV among imperfect adherent patients (Marcellin et al., 2011). Moreover,
psychological treatment is relevant to diminish the mortality rates in this population,
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because mental health impairment predicts mortality after transplant (Pérez-San-Gregorio,
Martín-Rodríguez, Galán-Rodríguez, and Borda-Más, 2009).
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